- Published at
- by manilatimes.net
neutral
neutral
News for Sesen Bio, Inc. (SESN)
- Published at
- by prnewswire.com
positivepositiveCarisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...- Published at
- by globenewswire.com
mixedmixedSAB Biotherapeutics Announces Appointment of Erick Lucera, CFA to Board of Directors
SIOUX FALLS, S.D., April 04, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel...- Published at
- by globenewswire.com
mixedmixedZevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors
CELEBRATION, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics (NasdaqGS: ZVRA) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare...- Published at
- by prnewswire.com
positivepositiveCarisma Therapeutics Closes Merger with Sesen Bio
/PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, and...- Published at
- by seekingalpha.com
neutralneutralSesen Bio stockholders approve 1-for-20 reverse stock split (NASDAQ:SESN)
Sesen Bio (SESN) stockholders on Thursday approved effecting a 1-for-20 reverse stock split of the company's issued and outstanding shares. Read more here.- Published at
- by seekingalpha.com
neutralneutralSesen Bio (SESN) Investor Presentation - Slideshow (NASDAQ:SESN)
The following slide deck was published by Sesen Bio, Inc.- Published at
- by seekingalpha.com
positivepositiveSesen Bio wins shareholder approval for Carisma merger (NASDAQ:SESN)
Sesen Bio (SESN) announced Thursday that its shareholders greenlighted the company’s pending merger with Carisma Therapeutics at a special stockholder meeting. Read the full story here.- Published at
- by seekingalpha.com
positivepositiveSesen Bio GAAP EPS of -$0.04 beats by $0.07 (NASDAQ:SESN)
Sesen Bio press release (SESN): Q4 GAAP EPS of -$0.04 beats by $0.07.Cash, cash equivalents and marketable securities were $166.9 million as of December 31, 2022, compared to cash...- Published at
- by prnewswire.com
mixedmixedSHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...- Published at
- by investing.com
positivepositive5 big dividend moves: Group 1 Automotive hikes by 20%
5 big dividend moves: Group 1 Automotive hikes by 20% | Pro Recap- Published at
- by prnewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MAXR, SESN, IMRA, ELVT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...- Published at
- by benzinga.com
positivepositiveUS Stocks Edge Higher As Fed Raises Interest Rates By 75 Basis Points - Adamis Pharmaceuticals (NASDAQ:ADMP), Evaxion Biotech (NASDAQ:EVAX)
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed.- Published at
- by benzinga.com
mixedmixed95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.YMTXWVEVRATIGRN.MXTIGRSMFRSHLSSESNSECOSBETRLXQUBTNEONMFMDJHLIDRLIAN.MXLIIQIOM.VGENIFUTUN.MXFUTUFTCIEOSEWEOSEEARDXFDQN.MXDQDIDICISOBZBKTIBGRYWBGRYATIFATHXASPUASPNARHHDARHHAPIANEBAEYE0I74.LZSANYCBD-PAYCBDVYGR.MXVYGRVIEWWVIEWUONEKUONETCMDSQFLSHCRRRGBOWLTHUMAGEVO.MXGEVOENDPCELUARRYACER0Y5F.L0A41.LPRAXNEGGJKSN.MXJKSEFTRCARV- Published at
- by etfdailynews.com
mixedmixedStock Analysts’ Upgrades for June 3rd (AI, ATNM, AXL, BANF, BPOP, CHUY, DLTH, EFTR, EONGY, ESEA)
Read Stock Analysts’ Upgrades for June 3rd (AI, ATNM, AXL, BANF, BPOP, CHUY, DLTH, EFTR, EONGY, ESEA) at ETF Daily News- Published at
- by etfdailynews.com
mixedmixedResearch Analysts’ Upgrades for April 23rd (ASX, BGFV, LIQT, LVTX, LYSDY, NGL, NWN, OLCLY, PSNL, RC)
Read Research Analysts’ Upgrades for April 23rd (ASX, BGFV, LIQT, LVTX, LYSDY, NGL, NWN, OLCLY, PSNL, RC) at ETF Daily News- Published at
- by markets.businessinsider.com
mixedmixed- Published at
- by markets.businessinsider.com
mixedmixed- Published at
- by investing.com
mixedmixedU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%SSFO34.SAREGN34.SAREGN.MXREGNPMCBDPMCBGRNVWGRNVUGRNVRGRNVFOO.DEFLGCEBAY.MXEBAY.BAEBAYEBA.DECRMD.BACRM.MXCRM.BACRMAMD.MXAMD.DEAMDA1MD34.SA0R2M.LTLMDWTLMDMSFT.SNMSFT.MXMSFTMSF.DEMSF.BRJPMMLJPMCL.SNJPMC.BAJPMAXP.MXAXPAEC1.DE0R3C.LSESNHPQB34.SAHPQ.SNHPQ.MXHPQ.BAHPQFANG.MXFANGF1AN34.SADUOTBACL.SNAPA.MXAPA.DEAPAA1PA34.SA7HP.DE0J2E.L0HGC.L- Published at
- by markets.businessinsider.com
mixedmixedThe Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...ZIVOPFED.BAPFECL.SNPFE.MXPFE.DEPFEMDNA.TOMDNAJAZZHARPFUSNCODXCAPRBNTXN.MXBNTX0A50.L0A3M.LZLDPFZIOPZGNXZEALXCURVYNEVYGR.MXVYGRVECTTXMDTRVNTRIL.TOTRILTLGTTFFPTARASPRBSONNRVMDRPIDRMTIPROGPRAXPMCBDPMCBPBLAPASGORTXNKTRNBIXMRNA.MXMRNAMNOVMBRXM1RN34.SALVTXLUMOLMNLKRONKPTIKNSAJAGXITRMIRWDIRTCINCYINABIMRAIKTI1NC34.SAHRTXHOTHHOOKHBIOGTBPGRFSGRFPN.MXGRF.MCGIS.DEGILDD.BAGILD.MXGILDGIKLYGIFOFGIFLFFMTXFLXNFGEN.MXFGENEYEGEWTXEPZMENSCWENSCDVAXDRNADMACCTMXCLRBCELUBXRXBUWA.DEBPTHBMEABIOLBIO-BBIOBDSXBAX.MXBAXAYTUAXSMATAIARDSALLOALKSALIMAKROAGLEACHLACAD4875.T0UNL.L0QK8.L0M3O.L0K6R.L0J9P.L0J4V.L0IL8.L0IDA.L0HKF.L0A8M.L0A7L.L0A4W.L0A45.LSESNJNJINVADJNJ3.BADJNJ2.BAARNAAPREABVC0S54.L